These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2554513

  • 1. Small cell lung cancer in a patient with neutropenia due to Felty's syndrome.
    Avery AD, Baumann MA.
    South Med J; 1989 Nov; 82(11):1452-3. PubMed ID: 2554513
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in Felty's syndrome.
    Pixley JS, Yoneda KY, Manalo PB.
    Am J Hematol; 1993 Aug; 43(4):304-6. PubMed ID: 7690520
    [Abstract] [Full Text] [Related]

  • 5. Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor.
    Wandt H, Seifert M, Falge C, Gallmeier WM.
    Ann Hematol; 1993 May; 66(5):265-6. PubMed ID: 7685194
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic chemotherapy for cancer in Felty's syndrome: role of lithium carbonate.
    Pazdur R, Rossof AH.
    Blood; 1981 Sep; 58(3):440-3. PubMed ID: 6789838
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Remission of neutropenia in a case of Felty's syndrome by rhG-CSF.
    Nielsen H, Mejer J.
    Scand J Rheumatol; 1992 Sep; 21(6):305-7. PubMed ID: 1282275
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A phase I study of pegylated liposomal doxorubicin hydrochloride (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small-cell lung cancer.
    Leighl NB, Burkes RL, Dancey JE, Lopez PG, Higgins BP, David Walde PL, Rudinskas LC, Rahim YH, Rodgers A, Pond GR, Shepherd FA.
    Clin Lung Cancer; 2003 Sep; 5(2):107-12. PubMed ID: 14596693
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome.
    Abdou NI.
    Arthritis Rheum; 1983 Aug; 26(8):947-53. PubMed ID: 6224491
    [Abstract] [Full Text] [Related]

  • 16. Felty's syndrome without rheumatoid arthritis?
    Rozin A, Hoffman R, Hayek T, Balbir-Gurman A.
    Clin Rheumatol; 2013 May; 32(5):701-4. PubMed ID: 23292482
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of granular lymphocyte proliferation in patients with rheumatoid arthritis and neutropenia.
    Saway PA, Prasthofer EF, Barton JC.
    Am J Med; 1989 Mar; 86(3):303-7. PubMed ID: 2919611
    [Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer.
    Bunn PA, Greco FA, Einhorn L.
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):45-53. PubMed ID: 3020700
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.